Press Release

Printer Friendly Version View printer-friendly version
<< Back
Dextera Surgical’s Automated Cardiac Anastomotic Devices to Be Featured at 2017 International Coronary Congress

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 17, 2017-- Dextera Surgical Inc. (Nasdaq:DXTR), a company manufacturing and marketing the only automated anastomotic devices for CABG surgery on the market, today announced that its C-Port® Distal and PAS-Port® Proximal Anastomosis Systems will be highlighted in multiple lectures, abstracts and presentations for their ability to enable less invasive cardiac procedures at the 2017 International Coronary Congress (ICC), a medical meeting focused on state-of-the-art surgical coronary revascularization. The meeting will be held August 18-20, 2017, in New York, NY.

Several presentations at the meeting highlight the use of Dextera’s C-Port and PAS-Port Systems to help enable less invasive coronary artery bypass graft (CABG) procedures. These include:

Abstract A07: Ps Matched Analysis of On-pump, Off-pump PAS-Port and Anaortic CABG – A Single Center Study in 5422 Patients
Session 8B, 4:26 p.m. to 4:32 p.m., Friday, August 18, 2017
Presenter: Prof. Dr. Med. Jan Gummert of Herz-und Diabeteszentrum Nordrhein-Westfalen in Bad Oeynhausen Germany

Abstract A26: How to Select Proximal Anastomotic Devices and Procedures to Avoid Perioperative Stroke in CABG
Session 9, 7:36 a.m. to 7:42 a.m., Saturday, August 19, 2017
Presenter: Dr. Tomohiro Mizuno of Tokyo Medical and Dental University in Japan

Abstract: Angiographic Outcomes with ‘Minimally Invasive’ CABG from Around the World
Session 16A, 4:03 p.m. to 4:11 p.m., Saturday, August 19, 2017
Presenter: Husam H. Balkhy, University of Chicago Medicine, Chicago, IL

Abstract: Robotic CABG: Role of Anastomotic Connectors
Session 18A, 8:40 a.m. to 8:48 a.m., Sunday, August 20, 2017
Presenter: Husam H. Balkhy, University of Chicago Medicine, Chicago, IL

“It’s an exciting time in the field of cardiac surgery today,” commented Dr. Balkhy, professor of surgery and director of robotic and minimally invasive cardiac surgery at the University of Chicago Medicine. “In presenting data from around the world at this meeting, it is clear that minimally invasive coronary surgery is on the rise. I’m pleased to report that the automated C-Port® Flex-A® System which I have been using in my practice for 10 years now, precisely and reliably connects the graft to the coronary arteries during coronary bypass procedures. It continues to enable minimally invasive and endoscopic approaches with remarkable outcomes in my patients. They consistently are discharged sooner and recover more quickly than patients undergoing a traditional open-heart coronary bypass, given the minimally invasive nature of the procedures.”

“The body of evidence supporting the use of automated anastomosis products during cardiac bypass procedure continues to grow, with diverse patient populations benefiting from these devices,” said Prof. Dr. Med. Gummert of Herz-und Diabeteszentrum Nordrhein-Westfalen in Bad Oeynhausen Germany. “I have used the PAS-Port System routinely in bypass procedures, because there is no need to clamp or manipulate the aorta during the procedure, an activity known to increase the risk of stroke.”

“We are pleased to see global leaders in cardiac surgery demonstrating the long-term clinical results using the C-Port and PAS-Port Systems in minimally invasive cardiac surgery in efforts to improve patient outcomes,” said Julian Nikolchev, president and CEO of Dextera Surgical. “These important tools continue to enable leading surgeons to perform bypass procedures less invasively as the only automated anastomosis products on the market today.”

About the C-Port® Distal Anastomosis Systems (C-Port systems)

The C-Port Anastomosis Systems are intended for use in the creation of anastomoses in blood vessels and grafts, including use in coronary artery bypass grafting procedures. The C-Port Systems – the C-Port xA System and the Flex-A® System – can be used on- or off-pump and create compliant anastomoses that expand and contract with blood flow. The C-Port Systems work on coronary arteries as small as 1.3 millimeters in internal diameter and work with grafts of various diameters and vessels with single wall thicknesses less than 0.75 millimeters. The Flex-A System allows surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. The C-Port System received 510(k) clearance in 2006 and the Flex-A System in 2007.

About the PAS-Port® Proximal Anastomosis System

The PAS-Port® System is intended to create the aortic anastomosis of aortic autologous vein grafts. The PAS-Port system is a fully-automated device used to perform an anastomosis between a saphenous vein and the aorta during either on- or off-pump CABG surgery. The PAS-Port system has been used in Japan and Europe since 2004, and received 510(k) clearance in the United States in 2008. The PAS-Port system allows a surgeon to complete an automated connection of the bypass graft vessel to the aorta (known as a proximal anastomosis) without the need to clamp and manipulate the aorta. The common method of completing a proximal anastomosis in CABG surgery often requires that the aorta be clamped and utilizes time-consuming hand-sewn sutures. When the clamp is released, tiny blood clots or particles from the aortic wall can be released, which can then travel to the brain and cause stroke and other neurologic complications. In addition, the PAS-Port's unique design allows for a comparable take-off angle when compared to hand-sewn sutures, and the PAS-Port's implant design does not introduce metal into the graft lumen.

About Dextera Surgical

Dextera Surgical designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.

Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.

Forward-Looking Statements

The statements in this press release regarding the benefits patients may obtain from the use of Dextera Surgical’s C-Port and PAS-Port Systems are "forward-looking statements." There are several important factors that could cause Dextera Surgical’s results to differ materially from those indicated by these forward-looking statements, including the risks detailed from time to time in Dextera Surgical’s reports filed with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, under the caption “Risk Factors.” Dextera Surgical expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Dextera Surgical’s reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.

Source: Dextera Surgical Inc.

Dextera Surgical Inc.
Bob Newell, 650-331-7133
Vice President, Finance and Chief Financial Officer
investors@dexterasurgical.com